Jefferson Health - Asplundh Cancer Pavilion — Willow Grove, Pennsylvania

Jefferson Health - Asplundh Cancer Pavilion is a clinical research site located in Willow Grove, Pennsylvania, United States 19090.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Jefferson Health - Asplundh Cancer Pavilion has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7.

Sponsors: Genmab, Thomas Jefferson University.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Willow Grove

Browse all research sites in Pennsylvania · View every site in Willow Grove

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jefferson Health - Asplundh Cancer Pavilion?

Jefferson Health - Asplundh Cancer Pavilion has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jefferson Health - Asplundh Cancer Pavilion conducted?

Jefferson Health - Asplundh Cancer Pavilion has 2 clinical trials on record, with 1 currently active. Their work covers Platinum-resistant Ovarian Cancer, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7.

Is Jefferson Health - Asplundh Cancer Pavilion accredited by Crixeo Clinical Trials?

Jefferson Health - Asplundh Cancer Pavilion has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jefferson Health - Asplundh Cancer Pavilion?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.